The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Hit and lead generation: beyond high-throughput screening
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Integration of virtual and high-throughput screening
Bajorath, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd941 · Cited by 930
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Bissantz, C., Folkers, G., & Rognan, D. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm001044l · Cited by 740
Combinatorial Synthesis of Small Organic Molecules
Balkenhohl, F., von dem Bussche‐Hünnefeld, C., Lansky, A., & Zechel, C. (1996) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199622881 · Cited by 726
“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening
Schneider, G., Neidhart, W., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19<2894::aid-anie2894>3.0.co;2-f · Cited by 717
Walters, W. P., & Murcko, M. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00003-0 · Cited by 439
Böhm, H.-J. (1998) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1007999920146 · Cited by 431
Self-citationADMET—turning chemicals into drugs
Hodgson, J. (2001) · Nature Biotechnology · doi:10.1038/90761 · Cited by 423
Virtual screening and fast automated docking methods
Schneider, G., & Böhm, H.-J. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02091-8 · Cited by 404
Self-citationA Scoring Scheme for Discriminating between Drugs and Nondrugs
Sadowski, J., & Kubinyi, H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9706776 · Cited by 392
Chapter 26. Privileged structures — An update
Patchett, A. A., & Nargund, R. P. (2000) · Annual Reports in Medicinal Chemistry · doi:10.1016/s0065-7743(00)35027-8 · Cited by 302
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
Roche, O., Schneider, P., Zuegge, J., Guba, W., Kansy, M., Alanine, A., Bleicher, K., Danel, F., Gutknecht, E.-M., Rogers-Evans, M., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010934d · Cited by 248
Self-citation3-D Pharmacophores in Drug Discovery
Mason, J., Good, A., & Martin, E. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397843 · Cited by 232
Target selection in drug discovery
Knowles, J., & Gromo, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd986 · Cited by 216
Clustering of Large Databases of Compounds: Using the MDL “Keys” as Structural Descriptors
McGregor, M. J., & Pallai, P. V. (1997) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci960151e · Cited by 181
Virtual Screening for Bioactive Molecules
(2000) · Methods and Principles in Medicinal Chemistry · doi:10.1002/9783527613083 · Cited by 167
Chemical genetic approaches for the elucidation of signaling pathways
Alaimo, P. J., Shogren‐Knaak, M. A., & Shokat, K. M. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00215-5 · Cited by 140
Automated chemical hypothesis generation and database searching with Catalyst®
Sprague, P. W. (1995) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02174464 · Cited by 123
Structure-based screening of low-affinity compounds
Carr, R. A. E., & Jhoti, H. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02245-6 · Cited by 112
Identification of four novel human G protein-coupled receptors expressed in the brain
Lee, D.-K., George, S. R., Cheng, R., Nguyen, T., Liu, Y., Brown, M., Lynch, K. R., & O’Dowd, B. F. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00242-4 · Cited by 101
Liebeschuetz, J. W., Jones, S. D., Morgan, P. J., Murray, C. W., Rimmer, A. D., Roscoe, J. M. E., Waszkowycz, B., Welsh, P. M., Wylie, W. A., Young, S. C., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010944e · Cited by 86
Schneider, G., Clément‐Chomienne, O., Hilfiger, L., Schneider, P., Kirsch, S. F., Böhm, H., & Neidhart, W. L. (2000) · PubMed · Cited by 85
Self-citationChemical ligands, genomics and drug discovery
Lenz, G. R., Nash, H. M., & Jindal, S. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01468-9 · Cited by 84
Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design
Schneider, G., Clément‐Chomienne, O., Hilfiger, L., Schneider, P., Kirsch, S. F., Böhm, H., & Neidhart, W. L. (2000) · Angewandte Chemie International Edition · Cited by 84
Self-citationA validation study on the practical use of automated de novo design
Ståhl, M., Todorov, N. P., James, T., Mauser, H., Boehm, H.-J., & Dean, P. M. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1021242018286 · Cited by 79
Structure-based screening and design in drug discovery
van Dongen, M. J. P., Weigelt, J., Uppenberg, J., Schultz, J., & Wikström, M. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02233-x · Cited by 71
Lead Generation - Enhancing the Success of Drug Discovery by Investing in the Hit to Lead Process
Alanine, A. I., Nettekoven, M. H., Roberts, E., & Thomas, A. W. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207033329823 · Cited by 59
Self-citationChemistry Space Metrics in Diversity Analysis, Library Design, and Compound Selection
Menard, P. R., Mason, J. S., Morize, I., & Bauerschmidt, S. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9801062 · Cited by 44
In silico identification of novel therapeutic targets
Duckworth, D. M., & Sanséau, P. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02282-1 · Cited by 15
Cited by
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
Lab-on-a-chip: microfluidics in drug discovery
Dittrich, P. S., & Manz, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1985 · Cited by 1,844
Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17
Ruddigkeit, L., van Deursen, R., Blum, L. C., & Reymond, J.-L. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300415d · Cited by 1,505
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Impact of high-throughput screening in biomedical research
Macarron, R., Banks, M. N., Bojanic, D., Burns, D. J., Cirovic, D. A., Garyantes, T., Green, D. V. S., Hertzberg, R. P., Janzen, W. P., Paslay, J. W., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3368 · Cited by 1,364
Metadata
- Authors
- Bleicher, K. H., Böhm, H.-J., Müller, K., & Alanine, A. I.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-05
- Volume
- 2
- Issue
- 5
- Pages
- 369-378
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2792455800
- Cited by
- 1,056
- References
- 36
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.